The Hybrid Catheterization Laboratory

  • Ralf J. HolzerEmail author


Hybrid procedures encompass the procedural cooperation between cardiothoracic surgeon and interventional cardiologist. These procedures include therapies such as hybrid palliation of hypoplastic left heart syndrome, perventricular VSD closure, and intraoperative stent placement [1–6]. An increasing number of centers has been embracing hybrid therapies [7], with the most important ingredient for the success of a hybrid program being the attitude of the interventional and surgical team, embracing a collaborative approach and being able to “think outside the box” when combining surgical and interventional techniques. While hybrid procedures can be performed with the right attitude and a portable c-arm, having a dedicated hybrid cardiac catheterization suite definitely reduces the difficulties in performing these procedures. It is therefore important to consider carefully whether to upgrade a cath lab to a dedicated hybrid catheterization suite.


Control Room Hypoplastic Left Heart Syndrome Catheterization Laboratory Hybrid Procedure Hybrid Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Michel-Behnke I, Akintuerk H, Marquardt I, et al. Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart. 2003;89(6):645–50.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Galantowicz M, Cheatham JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol. 2005;26(2):190–9.CrossRefGoogle Scholar
  3. 3.
    Galantowicz M, Cheatham JP. Fontan completion without surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:48–55.CrossRefPubMedGoogle Scholar
  4. 4.
    Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126(6):1718–23.CrossRefPubMedGoogle Scholar
  5. 5.
    Bacha EA, Cao QL, Galantowicz ME, et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol. 2005;26(2):169–75.CrossRefPubMedGoogle Scholar
  6. 6.
    Hjortdal VE, Redington AN, de Leval MR, Tsang VT. Hybrid approaches to complex congenital cardiac surgery. Eur J Cardiothorac Surg. 2002;22(6):885–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Holzer R, Marshall A, Kreutzer J, et al. Hybrid procedures: adverse events and procedural characteristics—results of a multi-institutional registry. Congenit Heart Dis. 2010;5(3):233–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Bonatti J, Vassiliades T, Nifong W, et al. How to build a cath-lab operating room. Heart Surg Forum. 2007;10(4):E344–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Hirsch R. The hybrid cardiac catheterization laboratory for congenital heart disease: from conception to completion. Catheter Cardiovasc Interv: Off J Soc Cardiac Angiogr Interv. 2008;71(3):418–28.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Cardiac Catheterization & Interventional Therapy, Division Chief Cardiology (Acting)Sidra Cardiovascular Center of Excellence, Sidra Medical and Research CenterDohaQatar

Personalised recommendations